| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| AHI1-CHEK2-20-RERE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-REOR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-REGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-REGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-REAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-ORRE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-OROR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-ORGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-ORGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-ORAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GORE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GOOR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GOGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GOGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GOAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GRRE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GROR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GRGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GRGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-GRAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-AQRE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-AQOR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-AQGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-AQGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| AHI1-CHEK2-20-AQAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Gene Symbol : CHEK2
Gene Name : Checkpoint kinase 2
Chromosome : CHR 22: 287,418,65-286,877,42
Locus : 22q12.1
This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
Gene Symbol : AHI1
Gene Name : Abelson helper integration site 1
Chromosome : CHR 6: 135,497,774-135,283,971
Locus : 6q23.3
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.